Results for tag: "Tuberous Sclerosis Complex Drug"

The Tuberous Sclerosis Complex (TSC) Drug market is a subset of the Central Nervous System (CNS) Drugs market. TSC is a rare genetic disorder that causes non-malignant tumors to form in various organs, including the brain, kidneys, heart, and lungs. TSC drugs are used to treat the symptoms of the disorder, such as seizures, cognitive impairment, and behavioral problems. These drugs are typically prescribed in combination with other treatments, such as surgery, radiation, and lifestyle modifications. The TSC Drug market is highly competitive, with a number of companies offering products for the treatment of TSC. These companies include Novartis, Pfizer, Eisai, and Otsuka Pharmaceuticals. Other companies in the market include Sunovion Pharmaceuticals, Shire, and Takeda Pharmaceuticals. Show Less Read more